Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Pteramina
2. 4-aminopteroylglutamic Acid
3. 4-aminofolic Acid; Apga
4. 2-(4-((2,4-diaminopteridin-6-yl)methylamino)-benzamido)pentanedioic Acid
5. 4-amino-4-deoxypteroylglutamate
6. Folic Acid, 4-amino-
7. N-[(4-{[(2,4-diaminopteridin-6-yl)methyl]amino}phenyl)carbonyl]glutamic Acid
8. 1236566-87-2
9. N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]glutamic Acid
10. 4-aminopteroyl-glutamic Acid
11. Aminofolic Acid, 4-
12. Sr-01000075636
13. Nsc739
14. 4-aminofolate
15. Ncgc00015038-03
16. 4-aminopteroylglutamate
17. Spectrum_001874
18. Specplus_000899
19. Spectrum2_000893
20. Spectrum3_001386
21. Spectrum4_000917
22. Spectrum5_000931
23. A 1784
24. Schembl8887
25. Lopac0_000034
26. Bspbio_002972
27. Kbiogr_001414
28. Kbioss_002396
29. Mls002153337
30. Divk1c_006995
31. Spectrum1500679
32. Spbio_000706
33. Chembl274619
34. Schembl8161477
35. Kbio1_001939
36. Kbio2_002391
37. Kbio2_004959
38. Kbio2_007527
39. Kbio3_002192
40. Dtxsid10858993
41. Hms1921c08
42. Hms3260g09
43. Pharmakon1600-01500679
44. Tox21_500034
45. Ccg-39745
46. Nsc757427
47. Stl477234
48. Akos015854984
49. Lp00034
50. Nsc-757427
51. Sb17355
52. Sdccgsbi-0050023.p004
53. Ncgc00015038-02
54. Ncgc00015038-04
55. Ncgc00015038-05
56. Ncgc00015038-06
57. Ncgc00015038-07
58. Ncgc00015038-08
59. Ncgc00015038-09
60. Ncgc00015038-10
61. Ncgc00015038-12
62. Ncgc00093553-01
63. Ncgc00093553-02
64. Ncgc00093553-03
65. Ncgc00093553-04
66. Ncgc00093553-05
67. Ncgc00093553-06
68. Ncgc00260719-01
69. As-75721
70. Smr001230749
71. Sbi-0050023.p003
72. Db-052619
73. Eu-0100034
74. Ft-0622297
75. Ab00053283_04
76. Sr-01000075636-1
77. Sr-01000075636-5
78. Wln: T66 Bn Dn Gn Jnj Cz Ez H1mr Dvmyvq2vq
79. L-glutamic Acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-,
80. Glutamic Acid,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, L-
81. 2-(4-(((2,4-diaminopteridin-6-yl)methyl)amino)benzamido)pentanedioicacid
82. L-n-[p-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-glutamic Acid
83. 2-[[4-[[(2,4-diaminopteridine-6-yl)methyl]amino]benzoyl]amino]pentanedioic Acid
| Molecular Weight | 440.4 g/mol |
|---|---|
| Molecular Formula | C19H20N8O5 |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 9 |
| Exact Mass | 440.15566577 g/mol |
| Monoisotopic Mass | 440.15566577 g/mol |
| Topological Polar Surface Area | 219 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 674 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Aminopterin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aminopterin, including repackagers and relabelers. The FDA regulates Aminopterin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aminopterin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aminopterin supplier is an individual or a company that provides Aminopterin active pharmaceutical ingredient (API) or Aminopterin finished formulations upon request. The Aminopterin suppliers may include Aminopterin API manufacturers, exporters, distributors and traders.
Aminopterin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aminopterin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aminopterin GMP manufacturer or Aminopterin GMP API supplier for your needs.
A Aminopterin CoA (Certificate of Analysis) is a formal document that attests to Aminopterin's compliance with Aminopterin specifications and serves as a tool for batch-level quality control.
Aminopterin CoA mostly includes findings from lab analyses of a specific batch. For each Aminopterin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aminopterin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aminopterin EP), Aminopterin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aminopterin USP).
LOOKING FOR A SUPPLIER?
